Exome Sequencing of Bilateral Testicular Germ Cell Tumors Suggests Independent Development Lineages

Neoplasia (United States)

Volumn 17, Issue 2, 2015, Pages 167-174

  Brabrand, Sigmund ^a,b   Johannessen, Bjarne ^a,b   Axcrona, Ulrika ^a   Kraggerud, Sigrid M ^a,b   Berg, Kaja G ^a,b   Bakken, Anne C ^a,b   Bruun, Jarle ^a,b   Fosså, Sophie D ^a   Lothe, Ragnhild A ^a,b   Lehne, Gustav ^a   Skotheim, Rolf I ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STEM CELL FACTOR RECEPTOR; TUMOR PROTEIN;

ADULT; ARTICLE; BILATERAL CANCER; CIITA GENE; CLONAL VARIATION; CONTROLLED STUDY; EXOME SEQUENCING; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NEB GENE; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; SUPT6H GENE; TESTICULAR GERM CELL TUMOR; TESTIS TUMOR; TUMOR GENE; WHSC1 GENE; CELL LINEAGE; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; EXOME; GENETICS; GERMLINE MUTATION; NEOPLASM; PATHOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES;

ADULT; CELL LINEAGE; DNA MUTATIONAL ANALYSIS; EXOME; GERM-LINE MUTATION; HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SEQUENCE ANALYSIS, DNA; TESTICULAR NEOPLASMS;

EID: 84989323073     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2014.12.005     Document Type: Article

References (53)

1. [1] Znaor, A, Lortet-Tieulent, J, Jemal, A, Bray, F, International variations and trends in testicular cancer incidence and mortality. Eur Urol 65 (2014), 1095–1106.
2. [2] Looijenga, LHJ, Gillis, AJM, Stoop, H, Biermann, K, Oosterhuis, JW, Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl 34 (2011), e234–e251.
3. [3] Larsen, WJ, Gametogenesis, Fertilization and the First Week. Strauss, M, Stapf, V, Terry, D, (eds.) Human Embryology, 1997, Churchill Livingstone, New York, 1–4.
4. [4] Lawrence, MS, Stojanov, P, Mermel, CH, Robinson, JT, Garraway, LA, Golub, TR, Meyerson, M, Gabriel, SB, Lander, ES, Getz, G, Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505 (2014), 495–501.
5. [5] Vogelstein, B, Papadopoulos, N, Velculescu, VE, Zhou, S, Diaz, LA, Kinzler, KW, Cancer genome landscapes. Science 339 (2013), 1546–1558.
6. [6] Weinstein, JN, Collisson, EA, Mills, GB, Shaw, KR, Ozenberger, BA, Ellrott, K, Shmulevich, I, Sander, C, Stuart, JM, The cancer genome atlas pan-cancer analysis project. Nat Genet 45 (2013), 1113–1120.
7. [7] Biermann, K, Göke, F, Nettersheim, D, Eckert, D, Zhou, H, Kahl, P, Gashaw, I, Schorle, H, Büttner, R, c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213 (2007), 311–318.
8. [8] Coffey, J, Linger, R, Pugh, J, Dudakia, D, Sokal, M, Easton, DF, Timothy Bishop, D, Stratton, M, Huddart, R, Rapley, EA, Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature. Genes Chromosomes Cancer 47 (2008), 34–42.
9. [9] Sakuma, Y, Matsukuma, S, Yoshihara, M, Sakurai, S, Nishii, M, Kishida, T, Kubota, Y, Nagashima, Y, Inayama, Y, Sasaki, T, et al. Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan. Cancer Lett 259 (2008), 119–126.
10. [10] Looijenga, H, de Leeuw, H, van Oorschot, M, van Gurp, RJH, Stoop, H, Gillis, AJ, de Gouveia Brazao, CA, Weber, RF, Kirkels, WJ, van Dijk, T, et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 63 (2003), 7674–7678.
11. [11] Bignell, G, Smith, R, Hunter, C, Stephens, P, Davies, H, Greenman, C, Teague, J, Butler, A, Edkins, S, Stevens, C, et al. Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults. Genes Chromosomes Cancer 45 (2006), 42–46.
12. [12] Wang, L, Yamaguchi, S, Burstein, MD, Terashima, K, Chang, K, Ng, H-K, Nakamura, H, He, Z, Doddapaneni, H, Lewis, L, et al. Novel somatic and germline mutations in intracranial germ cell tumours. Nature 511 (2014), 241–245.
13. [13] Kunkel, LM, Smith, KD, Boyer, SH, Borgaonkar, DS, Wachtel, SS, Miller, OJ, Breg, WR, Jones, HW Jr., Rary, JM, Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A 74 (1977), 1245–1249.
14. [14] Li, H, Durbin, R, Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25 (2009), 1754–1760.
15. [15] Picard website. available at: http://picard.sourceforge.net/.
16. [16] Samtools website. available at: http://samtools.sourceforge.net/.
17. [17] DePristo, MA, Banks, E, Poplin, R, Garimella, KV, Maguire, JR, Hartl, C, Philippakis, AA, del Angel, G, Rivas, MA, Hanna, M, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43 (2011), 491–498.
18. [18] McKenna, A, Hanna, M, Banks, E, Sivachenko, A, Cibulskis, K, Kernytsky, A, Garimella, K, Altshuler, D, Gabriel, S, Daly, M, et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20 (2010), 1297–1303.
19. [19] Cibulskis, K, Lawrence, MS, Carter, SL, Sivachenko, A, Jaffe, D, Sougnez, C, Gabriel, S, Meyerson, M, Lander, ES, Getz, G, Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31 (2013), 213–219.
20. [20] 1000 Genomes Project Consortium, Abecasis, GR, Auton, A, Brooks, LD, DePristo, MA, Durbin, RM, Handsaker, RE, Kang, HM, Marth, GT, McVean, GA, An integrated map of genetic variation from 1,092 human genomes. Nature 491 (2012), 56–65.
21. [21] Wang, K, Li, M, Hakonarson, H, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 38, 2010, e164.
22. [22] Reva, B, Antipin, Y, Sander, C, Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res, 39, 2011, e118.
23. [23] Tamborero, D, Gonzalez-Perez, A, Perez-Llamas, C, Deu-Pons, J, Kandoth, C, Reimand, J, Lawrence, MS, Getz, G, Bader, GD, Ding, L, et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep, 3, 2013, 2650.
24. [24] Cancer Gene Census (CGC) website, Catalogue of Somatic Mutations in Cancer (COSMIC) version 68. available at: http://www.sanger.ac.uk/genetics/CGP/Census [accessed on 17.02.2014].
25. [25] Catalogue of Somatic Mutations in Cancer (COSMIC) version 68 website. available at: http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/ [accessed on 01.04.2014].
26. [26] Ruark, E, Seal, S, McDonald, H, Zhang, F, Elliot, A, Lau, K, Perdeaux, E, Rapley, E, Eeles, R, Peto, J, et al. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45 (2013), 686–689.
27. [27] Chung, CC, Kanetsky, PA, Wang, Z, Hildebrandt, MA, Koster, R, Skotheim, RI, Kratz, CP, Turnbull, C, Cortessis, VK, Bakken, AC, et al. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45 (2013), 680–685.
28. [28] Schumacher, FR, Wang, Z, Skotheim, RI, Koster, R, Chung, CC, Hildebrandt, MA, Kratz, CP, Bakken, AC, Bishop, DT, Cook, MB, et al. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet 22 (2013), 2748–2753.
29. [29] De Felici, M, Dolci, S, Pesce, M, Cellular and molecular aspects of mouse primordial germ cell migration and proliferation in culture. Int J Dev Biol 36 (1992), 205–213.
30. [30] Mamsen, LS, Brøchner, CB, Byskov, AG, Mollgard, K, The migration and loss of human primordial germ stem cells from the hind gut epithelium towards the gonadal ridge. Int J Dev Biol 56 (2012), 771–778.
31. [31] Sakuma, Y, Sakurai, S, Oguni, S, Hironaka, M, Saito, K, Alterations of the c-kit gene in testicular germ cell tumors. Cancer Sci 94 (2003), 486–491.
32. [32] Kemmer, K, Corless, CL, Fletcher, JA, McGreevey, L, Haley, A, Griffith, D, Cummings, OW, Wait, C, Town, A, Heinrich, MC, KIT mutations are common in testicular seminomas. Am J Pathol 164 (2004), 305–313.
33. [33] McIntyre, A, Summersgill, B, Grygalewicz, B, Gillis, AJM, Stoop, J, van Gurp, RJ, Dennis, N, Fisher, C, Huddart, R, Cooper, C, et al. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65 (2005), 8085–8089.
34. [34] Nakai, Y, Nonomura, N, Oka, D, Shiba, M, Arai, Y, Nakayama, M, Inoue, H, Nishimura, K, Aozasa, K, Mizutani, Y, et al. KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. Biochem Biophys Res Commun 337 (2005), 289–296.
35. [35] Willmore-Payne, C, Holden, JA, Chadwick, BE, Layfield, LJ, Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis. Mod Pathol 19 (2006), 1164–1169.
36. [36] Rapley, EA, Hockley, S, Warren, W, Johnson, L, Huddart, R, Crockford, G, Forman, D, Leahy, MG, Oliver, DT, Tucker, K, et al. Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 90 (2004), 2397–2401.
37. [37] Tomasetti, C, Vogelstein, B, Parmigiani, G, Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A 110 (2013), 1999–2004.
38. [38] Rey, RA, Musse, M, Venara, M, Chemes, HE, Ontogeny of the androgen receptor expression in the fetal and postnatal testis: Its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc Res Tech 72 (2009), 787–795.
39. [39] Burns, MB, Temiz, NA, Harris, RS, Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45 (2013), 977–983.
40. [40] Skotheim, RI, Lind, GE, Monni, O, Nesland, JM, Abeler, VM, Fosså, SD, Duale, N, Brunborg, G, Kallioniemi, O, Andrews, PW, et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65 (2005), 5588–5598.
41. [41] Bentas, W, Beecken, W-D, Glienke, W, Binder, J, Schuldes, H, Serum levels of basic fibroblast growth factor reflect disseminated disease in patients with testicular germ cell tumors. Urol Res 30 (2003), 390–393.
42. [42] Castillo-Ávila, W, Piulats, JM, Garcia del Muro, X, Vidal, A, Condom, E, Casanovas, O, Mora, J, Germà, JR, Capellà, G, Villanueva, A, et al. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. Clin Cancer Res 15 (2009), 3384–3395.
43. [43] Demoulin, J-B, Essaghir, A, PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev 25 (2014), 273–283.
44. [44] Kawagishi, J, Kumabe, T, Yoshimoto, T, Yamamoto, T, Structure, organization, and transcription units of the human α-platelet-derived growth factor receptor gene, PDGFRA. Genomics 30 (1995), 224–232.
45. [45] Bedi, U, Scheel, AH, Hennion, M, Begus-Nahrmann, Y, Rüschoff, J, Johnsen, SA, SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms. Oncogene, 2014 [in press].
46. [46] Skotheim, RI, Autio, R, Lind, GE, Kraggerud, SM, Andrews, PW, Monni, O, Kallioniemi, O, Lothe, RA, Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. Cell Oncol 28 (2006), 315–326.
47. [47] Wagner, K, Mincheva, A, Korn, B, Lichter, P, Pöpperl, H, Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. Mech Dev 103 (2001), 127–131.
48. [48] Hudlebusch, HR, Santoni-Rugiu, E, Simon, R, Ralfkiær, E, Rossing, HH, Johansen, JV, Jørgensen, M, Sauter, G, Helin, K, The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 17 (2011), 2919–2933.
49. [49] Xu, H, DiCarlo, J, Satya, RV, Peng, Q, Wang, Y, Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics, 15, 2014, 244.
50. [50] Wang, Q, Jia, P, Li, F, Chen, H, Ji, H, Hucks, D, Dahlman, KB, W Pao & Z Zhao 51, Skotheim, RI, Kraggerud, SM, Fosså, SD, Stenwig, AE, Gedde-Dahl, T Jr., Danielsen, HE, Jakobsen, KS, Lothe, RA, Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. Genome Med, 5, 2013, 91.
51. [51] Skotheim, RI, Kraggerud, SM, Fosså, SD, Stenwig, AE, Gedde-Dahl, T Jr., Danielsen, HE, Jakobsen, KS, Lothe, RA, Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence. Neoplasia 3 (2001), 196–203.
52. [52] Kraggerud, SM, Skotheim, RI, Szymanska, J, Eknæs, M, Fosså, SD, Stenwig, AE, Peltomäki, P, Lothe, RA, Genome profiles of familial/bilateral and sporadic testicular germ cell tumors. Genes Chromosomes Cancer 34 (2002), 168–174.
53. [53] Kratz, CP, Han, SS, Rosenberg, PS, Berndt, SI, Burdett, L, Yeager, M, Korde, LA, Mai, PL, Pfeiffer, R, Greene, MH, Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet 48 (2011), 473–476.